XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
JPM Warrant Transactions | Senior Convertible Notes due 2023 | Senior Notes | Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Exercise and settlement of warrants (in shares)   1.9    
Stock issued during period, shares, exercise and settlement of remaining warrants (in shares) 4.6      
Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Exercise and settlement of warrants (in shares) 4.6 7.9   12.5
Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)       1.5
Milestone Payments | Verily Life Sciences | Collaborative Arrangement        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)   1.5 3.7  
Restricted Stock Units (RSUs) and Performance Shares | Equity Incentive Plan 2015        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized estimated compensation costs $ 306.9     $ 306.9
Unrecognized compensation costs recognized weighted average period (in years)       2 years